MDXG
MiMedx Q3 2026 Sales Drop Amid Regulatory Shifts
MiMedx reported a 45% drop in net sales due to Wound Care declines, but delivered surgical volume growth and returned to positive Adjusted EBITDA.
MDXG news
Latest 2 stories · newest Oct 28, 2026
MDXG
MiMedx amends bylaws to allow remote shareholder meetings and adjust voting procedures
MiMedx Group updated its amended and restated bylaws to permit shareholders meetings via remote communication and modified special meeting procedures requiring 50% shareholder threshold. The governance changes provide operational flexibility while maintaining shareholder rights under Florida corpora…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same MDXG feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/MDXG/newsSTART FREE